
MRK Earnings: Merck & Co. Q1 adj. profit rises, beats estimates
Merck & Co. Inc. (NYSE: MRK) Thursday reported an increase in adjusted earnings for the first quarter of 2025, while the pharma company’s sales declined modestly. First-quarter sales were $15.5 billion, compared to $15.8 billion in the prior year …